The Journal of Community and Supportive Oncology Nasal septum perforation induced by bevacizumab therapy in patients with breast cancerAugust 1, 2012Breast Cancer
Oncology PracticeWashington Post Blasts Proliferation of ESAs for AnemiaJuly 20, 2012Breast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
Oncology PracticeBrain Mets in Breast Cancer: Breaking Through the BarrierJuly 20, 2012Neuro-oncologyBreast Cancer
Oncology PracticeGlaxoSmithKline Pulls Lapatinib Submission Ahead of ODAC ReviewJuly 13, 2012Breast Cancer
Oncology PracticeCochrane Review Revives Bevacizumab Debate in Metastatic Breast CancerJuly 10, 2012Breast Cancer
Oncology PracticeFDA Approves REMS for Long-Acting OpioidsJuly 9, 2012Breast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
Oncology PracticeFDA Warns of QT Prolongation with Ondansetron DoseJuly 9, 2012Breast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
The Journal of Community and Supportive OncologyAIP: Prospective Validation of a Prediction Tool for Identifying Patients at High Risk for Chemotherapy-Induced Nausea and Vomiting July 9, 2012Breast CancerPatient & Survivor Care
Oncology PracticeScalp Cooling Protects Against Chemotherapy-Induced AlopeciaJuly 5, 2012Breast CancerMelanomaPatient & Survivor Care
Oncology PracticeNICE Rejects Bevacizumab Plus Capecitabine for Breast CancerJuly 5, 2012Breast Cancer
The Journal of Community and Supportive OncologyBalancing the efficacy and safety of ixabepilone: optimizing treatment in metastatic breast cancerJuly 1, 2012Breast Cancer
The Journal of Community and Supportive OncologyIntrathecal trastuzumab: 46 months and no progressionJuly 1, 2012Breast Cancer
